These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2089086)

  • 1. Does moclobemide stimulate melatonin synthesis as the other selective MAO-A inhibitors do?
    Oxenkrug GF; Requintina PJ; Yuwiler A
    J Neural Transm Suppl; 1990; 32():171-5. PubMed ID: 2089086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic effect of the irreversible and reversible selective MAO-A inhibitors on rat pineal melatonin biosynthesis.
    Oxenkrug GF; Requintina PJ; McIntyre IM; White K
    J Neural Transm Suppl; 1994; 41():381-4. PubMed ID: 7523585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronopharmacological study of moclobemide effect on the rat pineal melatonin biosynthesis.
    Oxenkrug GF; Requintina PJ; White K; Yuwiler A
    J Neural Transm Suppl; 1994; 41():335-7. PubMed ID: 7931247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of selective monoamine oxidase inhibitors on rat pineal melatonin synthesis in vitro.
    Oxenkrug G; McIntyre I; McCauley R; Yuwiler A
    J Pineal Res; 1988; 5(1):99-109. PubMed ID: 2452867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible melatonin involvement in the hypotensive effect of MAO inhibitors.
    Oxenkrug GF; McCauley RB; Fontana DJ; McIntyre IM; Commissaris RL
    J Neural Transm; 1986; 66(3-4):271-80. PubMed ID: 3097249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of monoamine oxidase-A inhibition by moclobemide in vitro and ex vivo in rats.
    Kettler R; Da Prada M; Burkard WP
    Acta Psychiatr Scand Suppl; 1990; 360():101-2. PubMed ID: 2248058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of rat pineal melatonin synthesis: effect of monoamine oxidase inhibition.
    King TS; Richardson BA; Reiter RJ
    Mol Cell Endocrinol; 1982 Mar; 25(3):327-38. PubMed ID: 6279462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
    Gerardy J
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):793-802. PubMed ID: 7938567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the selective MAO-A inhibitors brofaromine, clorgyline and moclobemide on human platelet MAO-B activity.
    Gleiter CH; Nilsson E; Mühlbauer B; Antonin KH; Bieck PR
    J Neural Transm Gen Sect; 1992; 89(1-2):129-33. PubMed ID: 1418864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moclobemide, an inhibitor of MAO-A, does not increase daytime plasma melatonin levels in normal humans.
    Scheinin M; Koulu M; Vakkuri O; Vuorinen J; Zimmer RH
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):73-82. PubMed ID: 2300680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acute effect of the bioprecursor of the selective brain MAO-A inhibitor, MDL 72392, on rat pineal melatonin biosynthesis.
    Oxenkrug GF; Requintina PJ; Yuwiler A; Palfreyman MG
    J Neural Transm Suppl; 1994; 41():377-9. PubMed ID: 7931254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of MAO-A inhibition and cold-immobilization stress on N-acetylserotonin and melatonin in SHR and WKY rats.
    Oxenkrug GF; Requintina PJ
    J Neural Transm Suppl; 1998; 52():333-6. PubMed ID: 9564635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response of the pineal melatonin biosynthesis to the selective MAO-A inhibitor, clorgyline, in young and middle-aged rats.
    Oxenkrug GF; McIntyre IM; Requintina PJ; Duffy JD
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):895-902. PubMed ID: 1722343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Methoxytryptamine is metabolized by monoamine oxidase A in the pineal gland and plasma of golden hamsters.
    Raynaud F; Pévet P
    Neurosci Lett; 1991 Feb; 123(2):172-4. PubMed ID: 2027530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
    Kan JP; Steinberg R; Mouget-Goniot C; Worms P; Bizière K
    J Pharmacol Exp Ther; 1987 Jan; 240(1):251-8. PubMed ID: 3100771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of 6-months l-deprenyl administration on pineal MAO-A and MAO-B activity and on the content of melatonin and related indoles in aged female Fisher 344N rats.
    Oxenkrug GF; Requintina PJ; Correa RM; Yuwiler A
    J Neural Transm Suppl; 1994; 41():249-52. PubMed ID: 7931233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of [3H]brofaromine to monoamine oxidase A in vivo: displacement by clorgyline and moclobemide.
    Waldmeier PC; Stöcklin K
    Eur J Pharmacol; 1990 May; 180(2-3):297-304. PubMed ID: 2365007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine.
    Lavian G; Finberg JP; Youdim MB
    Clin Neuropharmacol; 1993; 16 Suppl 2():S1-7. PubMed ID: 8313392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors.
    Da Prada M; Kettler R; Keller HH; Burkard WP; Haefely WE
    J Neural Transm Suppl; 1989; 28():5-20. PubMed ID: 2677242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An iodinated derivative of moclobemide as potential radioligand for brain MAO-A exploration.
    Rafii H; Chalon S; Ombetta JE; Frangin Y; Pourcelot L; Besnard JC; Bodard S; Guilloteau D
    Life Sci; 1996; 58(14):1159-69. PubMed ID: 8614267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.